Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter.

Schragenheim J, Bellner L, Cao J, Singh SP, Bamshad D, McClung JA, Maayan O, Meissner A, Grant I, Stier CT Jr, Abraham NG.

Prostaglandins Other Lipid Mediat. 2018 Jul;137:30-39. doi: 10.1016/j.prostaglandins.2018.05.008. Epub 2018 May 19.

2.

Cardiovascular responses to intranasal neuropeptide Y in single prolonged stress rodent model of post-traumatic stress disorder.

Camp R, Stier CT Jr, Serova LI, McCloskey J, Edwards JG, Reyes-Zaragoza M, Sabban EL.

Neuropeptides. 2018 Feb;67:87-94. doi: 10.1016/j.npep.2017.11.006. Epub 2017 Nov 8.

PMID:
29169656
3.

Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels.

Carroll MA, Kang Y, Chander PN, Stier CT Jr.

Am J Hypertens. 2015 May;28(5):664-71. doi: 10.1093/ajh/hpu201. Epub 2014 Nov 10.

PMID:
25384409
4.

Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage.

Li J, Stier CT, Chander PN, Manthati VL, Falck JR, Carroll MA.

Front Pharmacol. 2014 Aug 15;5:187. doi: 10.3389/fphar.2014.00187. eCollection 2014.

5.

Vascular effects of high-salt intake.

Stier CT.

J Hypertens. 2013 Mar;31(3):472-3. doi: 10.1097/HJH.0b013e32835e8de1. No abstract available.

PMID:
23615208
6.

Serotonin and dopamine in essential hypertension.

Stier CT Jr.

Am J Hypertens. 2013 Feb;26(2):151. doi: 10.1093/ajh/hps085. Epub 2012 Dec 28. No abstract available.

7.

Tumor necrosis factor-alpha induces renal cyclooxygenase-2 expression in response to hypercalcemia.

Battula S, Hao S, Pedraza PL, Stier CT, Ferreri NR.

Prostaglandins Other Lipid Mediat. 2012 Oct;99(1-2):45-50. doi: 10.1016/j.prostaglandins.2012.07.001. Epub 2012 Jul 16.

8.

Tumor necrosis factor-alpha is an endogenous inhibitor of Na+-K+-2Cl- cotransporter (NKCC2) isoform A in the thick ascending limb.

Battula S, Hao S, Pedraza PL, Stier CT, Ferreri NR.

Am J Physiol Renal Physiol. 2011 Jul;301(1):F94-100. doi: 10.1152/ajprenal.00650.2010. Epub 2011 Apr 20.

9.

Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.

Jiang H, Quilley J, Doumad AB, Zhu AG, Falck JR, Hammock BD, Stier CT Jr, Carroll MA.

Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H1990-6. doi: 10.1152/ajpheart.01267.2010. Epub 2011 Mar 11.

10.

TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion.

Chen CC, Pedraza PL, Hao S, Stier CT, Ferreri NR.

Am J Physiol Renal Physiol. 2010 Nov;299(5):F1141-50. doi: 10.1152/ajprenal.00344.2010. Epub 2010 Aug 25.

11.

Aldosterone and angiogenesis.

Stier CT.

Am J Hypertens. 2010 Sep;23(9):940. doi: 10.1038/ajh.2010.155. No abstract available.

PMID:
20733574
12.

Mineralocorticoid receptors in myocardial infarction.

Stier CT Jr.

Hypertension. 2009 Dec;54(6):1211-2. doi: 10.1161/HYPERTENSIONAHA.109.140384. Epub 2009 Oct 19. No abstract available.

PMID:
19841284
13.

Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.

Liclican EL, Doumad AB, Wang J, Li J, Falck JR, Stier CT Jr, Carroll MA.

Hypertension. 2009 Dec;54(6):1284-90. doi: 10.1161/HYPERTENSIONAHA.108.123570. Epub 2009 Oct 12.

14.

Kinetics and persistence of cardiovascular and locomotor effects of immobilization stress and influence of ACTH treatment.

Sabban EL, Schilt N, Serova LI, Masineni SN, Stier CT Jr.

Neuroendocrinology. 2009;89(1):98-108. doi: 10.1159/000150099. Epub 2008 Aug 13.

15.

Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.

Li J, Carroll MA, Chander PN, Falck JR, Sangras B, Stier CT.

Front Biosci. 2008 May 1;13:3480-7.

PMID:
18508449
16.

Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats.

Chun TY, Chander PN, Kim JW, Pratt JH, Stier CT Jr.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E305-12. doi: 10.1152/ajpendo.00512.2007. Epub 2008 May 20.

17.

Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.

Sepehrdad R, Frishman WH, Stier CT Jr, Sica DA.

Cardiol Rev. 2007 Sep-Oct;15(5):242-56. Review.

PMID:
17700383
18.

Osteopontin in patients with primary aldosteronism.

Stier CT Jr.

Am J Hypertens. 2006 Mar;19(3):298-9. No abstract available.

PMID:
16500517
19.

Eplerenone appears cost-effective for people with heart failure after acute myocardial infarction. Commentary 1.

Stier CT Jr.

Evid Based Cardiovasc Med. 2005 Sep;9(3):225-7. Epub 2005 Jul 26. No abstract available.

PMID:
16380038
20.

Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.

Botros FT, Schwartzman ML, Stier CT Jr, Goodman AI, Abraham NG.

Kidney Int. 2005 Dec;68(6):2745-55.

21.

Effect of aldosterone and MR blockade on the brain and the kidney.

Stier CT Jr, Rocha R, Chander PN.

Heart Fail Rev. 2005 Jan;10(1):53-62. Review.

PMID:
15947892
22.

Male gender and not the severity of hypertension is associated with end-organ damage in aged stroke-prone spontaneously hypertensive rats.

Masineni SN, Chander PN, Singh GD, Powers CA, Stier CT Jr.

Am J Hypertens. 2005 Jun;18(6):878-84.

PMID:
15925751
23.

Stress triggered rise in plasma aldosterone is lessened by chronic nicotine infusion.

Stier CT Jr, Serova LI, Singh G, Sabban EL.

Eur J Pharmacol. 2004 Jul 14;495(2-3):167-70.

PMID:
15249166
24.

Aldosterone and aldosterone antagonism in systemic hypertension.

Frishman WH, Stier CT Jr.

Curr Hypertens Rep. 2004 Jun;6(3):195-200. Review.

PMID:
15128471
25.

Sodium transport antagonism reduces thrombotic microangiopathy in stroke-prone spontaneously hypertensive rats.

Sepehrdad R, Chander PN, Singh G, Stier CT Jr.

Am J Physiol Renal Physiol. 2004 Jun;286(6):F1185-92. Epub 2004 Feb 24.

26.

Protective effects of dietary potassium chloride on hemodynamics of Dahl salt-sensitive rats in response to chronic administration of sodium chloride.

Manger WM, Simchon S, Stier CT Jr, Loscalzo J, Jan KM, Jan R, Haddy F.

J Hypertens. 2003 Dec;21(12):2305-13.

PMID:
14654751
27.

Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease.

Pitt B, Stier CT Jr, Rajagopalan S.

J Renin Angiotensin Aldosterone Syst. 2003 Sep;4(3):164-8. Review.

PMID:
14608520
28.

Eplerenone: a selective aldosterone blocker.

Stier CT Jr.

Cardiovasc Drug Rev. 2003 Fall;21(3):169-84. Review.

PMID:
12931252
29.

Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.

Chander PN, Rocha R, Ranaudo J, Singh G, Zuckerman A, Stier CT Jr.

J Am Soc Nephrol. 2003 Aug;14(8):1990-7.

30.

Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone (Inspra).

Stier CT Jr, Koenig S, Lee DY, Chawla M, Frishman WH.

Heart Dis. 2003 Mar-Apr;5(2):102-18. Review.

PMID:
12713678
31.

Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats.

Stier CT Jr, Chander PN, Rosenfeld L, Powers CA.

Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E232-9. Epub 2003 Apr 1.

32.

Amiloride reduces stroke and renalinjury in stroke-prone hypertensive rats.

Sepehrdad R, Chander PN, Oruene A, Rosenfeld L, Levine S, Stier CT Jr.

Am J Hypertens. 2003 Apr;16(4):312-8.

PMID:
12670749
33.
34.

Aldosterone as a mediator in cardiovascular injury.

Stier CT Jr, Chander PN, Rocha R.

Cardiol Rev. 2002 Mar-Apr;10(2):97-107. Review.

PMID:
11895576
35.

Pathophysiological effects of aldosterone in cardiovascular tissues.

Rocha R, Stier CT Jr.

Trends Endocrinol Metab. 2001 Sep;12(7):308-14. Review.

PMID:
11504670
36.

Ifetroban sodium: an effective TxA2/PGH2 receptor antagonist.

Rosenfeld L, Grover GJ, Stier CT Jr.

Cardiovasc Drug Rev. 2001 Summer;19(2):97-115. Review.

PMID:
11484065
37.

Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.

Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK.

Endocrinology. 2000 Oct;141(10):3871-8.

PMID:
11014244
38.

Inhibition of NOS enhances pulmonary vascular changes in stroke-prone spontaneously hypertensive rats.

Mathew R, Fan NY, Yuan N, Chander PN, Gewitz MH, Stier CT Jr.

Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L81-9.

39.

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats.

Rocha R, Chander PN, Zuckerman A, Stier CT Jr.

Hypertension. 1999 Jan;33(1 Pt 2):232-7.

PMID:
9931110
40.

Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats.

Fink J, Fan NY, Rosenfeld L, Stier CT Jr.

J Cardiovasc Pharmacol. 1998 Apr;31(4):618-22.

PMID:
9554813
41.

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr.

Hypertension. 1998 Jan;31(1 Pt 2):451-8.

PMID:
9453344
42.

Regional renal nitric oxide release in stroke-prone spontaneously hypertensive rats.

Zuckerman A, Chander PN, Zeballos GA, Stier CT Jr.

Hypertension. 1997 Dec;30(6):1479-86.

PMID:
9403570
43.

Beneficial action of beraprost sodium, a prostacyclin analog, in stroke-prone rats.

Stier CT Jr, Chander PN, Belmonte A, Inamdar RS, Mistry M.

J Cardiovasc Pharmacol. 1997 Sep;30(3):285-93.

PMID:
9300310
44.

Lack of antidiuretic activity of lanreotide in the diabetes insipidus rat.

Fan NY, Powers CA, Stier CT Jr.

J Pharmacol Exp Ther. 1996 Mar;276(3):875-81.

PMID:
8786564
45.

Effect of ifetroban, a thromboxane A2 receptor antagonist, in stroke-prone spontaneously hypertensive rats.

Johnson RA, Belmonte A, Fan NY, Lavesa M, Nasjletti A, Stier CT Jr.

Clin Exp Hypertens. 1996 Feb;18(2):171-88.

PMID:
8868999
46.

GM1 ganglioside treatment of spontaneously hypertensive stroke prone rats.

Hernandez NE, MacDonall JS, Stier CT Jr, Belmonte A, Fernandez R, Karpiak SE.

Exp Neurol. 1994 Mar;126(1):95-100.

PMID:
8157130
47.

Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.

Stier CT Jr, Adler LA, Levine S, Chander PN.

J Hypertens Suppl. 1993 Apr;11(3):S37-42.

PMID:
8315518
48.

Urinary dopamine and sodium excretion in spontaneously hypertensive rats.

Stier CT Jr, Itskovitz HD, Chen YH.

Clin Exp Hypertens. 1993 Jan;15(1):105-23.

PMID:
8467307
49.

Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney.

Stier CT Jr, Quilley CP, McGiff JC.

J Pharmacol Exp Ther. 1992 Jul;262(1):252-6.

PMID:
1625203
50.

Enhanced thromboxane formation by blood but not whole platelets from spontaneously hypertensive rats.

Stier CT Jr, Wong PY, Itskovitz HD.

Prostaglandins. 1992 Jun;43(6):533-44.

PMID:
1410518

Supplemental Content

Loading ...
Support Center